Hollak CE - Search Results

1

Gender- and Age-Associated Differences in Bone Marrow Adipose Tissue and Bone Marrow Fat Unsaturation Throughout the Skeleton, Quantified Using Chemical Shift Encoding-Based Water-Fat MRI.

Beekman KM, Regenboog M, Nederveen AJ, Bravenboer N, den Heijer M, Bisschop PH, Hollak CE, Akkerman EM, Maas M. Beekman KM, et al. Among authors: hollak ce. Front Endocrinol (Lausanne). 2022 Apr 27;13:815835. doi: 10.3389/fendo.2022.815835. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574007 Free PMC article.

2

Clinically relevant therapeutic endpoints in type I Gaucher disease.

Hollak CE, Maas M, Aerts JM. Hollak CE, et al. J Inherit Metab Dis. 2001;24 Suppl 2:97-105; discussion 87-8. doi: 10.1023/a:1012492429191. J Inherit Metab Dis. 2001. PMID: 11758685 Review.

3

Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.

Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Hollak C, et al. Blood Cells Mol Dis. 2001 Nov-Dec;27(6):1005-12. doi: 10.1006/bcmd.2001.0474. Blood Cells Mol Dis. 2001. PMID: 11831867

4

Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.

Maas M, Hollak CE, Akkerman EM, Aerts JM, Stoker J, Den Heeten GJ. Maas M, et al. Among authors: hollak ce. AJR Am J Roentgenol. 2002 Oct;179(4):961-5. doi: 10.2214/ajr.179.4.1790961. AJR Am J Roentgenol. 2002. PMID: 12239046

5

Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease.

Vlieger EJ, Maas M, Akkerman EM, Hollak CE, Den Heeten GJ. Vlieger EJ, et al. Among authors: hollak ce. J Comput Assist Tomogr. 2002 Sep-Oct;26(5):843-8. doi: 10.1097/00004728-200209000-00031. J Comput Assist Tomogr. 2002. PMID: 12439326

6

Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.

Maas M, van Kuijk C, Stoker J, Hollak CE, Akkerman EM, Aerts JF, den Heeten GJ. Maas M, et al. Among authors: hollak ce. Radiology. 2003 Nov;229(2):554-61. doi: 10.1148/radiol.2292020296. Epub 2003 Oct 2. Radiology. 2003. PMID: 14526090

7

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.

de Fost M, Hollak CE, Groener JE, Aerts JM, Maas M, Poll LW, Wiersma MG, Häussinger D, Brett S, Brill N, vom Dahl S. de Fost M, et al. Among authors: hollak ce. Blood. 2006 Aug 1;108(3):830-5. doi: 10.1182/blood-2005-12-5072. Epub 2006 Mar 9. Blood. 2006. PMID: 16527890 Free article.

8

Substrate reduction therapy of glycosphingolipid storage disorders.

Aerts JM, Hollak CE, Boot RG, Groener JE, Maas M. Aerts JM, et al. Among authors: hollak ce. J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):449-56. doi: 10.1007/s10545-006-0272-5. J Inherit Metab Dis. 2006. PMID: 16763917

9

Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.

Maas M, Hollak CE, Akkerman EM, Aerts JF. Maas M, et al. Among authors: hollak ce. JBR-BTR. 2006 Nov-Dec;89(6):318-21. JBR-BTR. 2006. PMID: 17274590

10

Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial.

de Fost M, Aerts JM, Groener JE, Maas M, Akkerman EM, Wiersma MG, Hollak CE. de Fost M, et al. Among authors: hollak ce. Haematologica. 2007 Feb;92(2):215-21. doi: 10.3324/haematol.10635. Haematologica. 2007. PMID: 17296571 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page